Is Pembrolizumab Appropriate Before EGFR TKI Therapy in Lung Cancer?

12:31 EDT 3 Jun 2018 | Cancer Networks
Jun 3, 2018

Administering pembrolizumab before EGFR TKIs may be inappropriate for TKI-naive patients with EGFR-mutant NSCLC.

Original Article: Is Pembrolizumab Appropriate Before EGFR TKI Therapy in Lung Cancer?

More From BioPortfolio on "Is Pembrolizumab Appropriate Before EGFR TKI Therapy in Lung Cancer?"